MARCHEX INC (MCHX): Completion of Acquisition or Disposition of Assets
MARCHEX INC (MCHX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. 8-K 0001224133 False 0001224133 2026-07-01 2026-07-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported): July 1 ,
How this was made
The 30-second read
Why it matters
The market will likely focus on (1) $10M convertible promissory notes (6% interest; conversion at $1.80/share; repayment in three tranches) and (2) potential additional issuance of 2M shares for each of the first two 12-month periods if revenue/Adjusted EBITDA and integration/retention targets are exceeded.
Market read
Deal-close mechanics provide actionable inputs for valuation/dilution modeling (conversion price, note tranches, and contingent share issuance tied to performance).
What to watch
Tranche structure (12/18/24-month note payments) and default/conversion mechanics could matter more than headline deal size; traders should model dilution sensitivity to whether targets are likely met.
Background
Marchex previously announced the Archenia acquisition and filed the Stock Purchase Agreement as an annex to a June 5, 2026 proxy; this 8-K confirms the July 1, 2026 closing and the consideration terms.
Ticker impact
Marchex closed its acquisition of Archenia on July 1, issuing $10M convertible notes and potential 4M Class B shares contingent on performance.
Likely modest volatility around deal-close/dilution expectations; direction depends on perceived quality of Archenia’s performance targets and integration risk.
The filing discloses concrete consideration terms (6% convertible notes, $1.80 conversion price, tranche timing, and up to 4M shares over two 12-month periods) but provides no standalone financial results or guidance for MCHX beyond deal mechanics.
Market effects
Adds another example of performance-marketing/MarTech consolidation using AI-driven customer qualification; may influence deal expectations in adjacent ad-tech niches.
Limited; transaction is company-specific with no disclosed regional macro linkage.
Low; no cross-border regulatory or macro catalyst disclosed.
Counterpoint
If Archenia’s revenue/Adjusted EBITDA and retention targets are credible, the contingent share issuance could be viewed as value-accretive rather than dilutive, supporting a more constructive read-through.
Key entities
- companyMarchex, Inc.
Nasdaq-listed acquirer that closed the Archenia transaction and issued convertible notes plus contingent share consideration.
- companyArchenia, Inc.
Performance-based marketing technology company acquired by Marchex; its assets support customer qualification and acquisition using AI/analytics.
- personRussell C. Horowitz
Marchex Chairman and one of the sellers receiving consideration under the Stock Purchase Agreement.
- personMichael Arends
Marchex Vice Chairman and one of the sellers receiving consideration under the Stock Purchase Agreement.
